Non-alcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) in living-donor liver transplantation (LDLTX)

被引：0
|
作者：
Yamamoto, K [1 ]
Takada, Y [1 ]
Fujimoto, Y [1 ]
Haga, H [1 ]
Egawa, H [1 ]
Tanaka, K [1 ]
机构：
[1] Kyoto Univ, Dept Transplanta & Immunol, Kyoto, Japan
来源：
LIVER TRANSPLANTATION | 2004年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
116
引用
收藏
页码：C29 / C29
页数：1
相关论文
共 50 条
  • [21] Nicht alkoholische Fettleberkrankheit (NAFLK) Steatosis hepatis — NASH Non-alcoholic fatty liver disease (NAFLD) Non-alcoholic steatohepatitis − NASH
    K.-M. Keller
    Monatsschrift Kinderheilkunde, 2004, 152 : 864 - 869
  • [22] A single non-invasive model to diagnose non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Otgonsuren, Munkhzul
    Estep, Michael J.
    Hossain, Nayeem
    Younossi, Elena
    Frost, Spencer
    Henry, Linda
    Hunt, Sharon
    Fang, Yun
    Goodman, Zachary
    Younossi, Zobair M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (12) : 2006 - 2013
  • [23] Liver stiffness measurement using transient elastography in patients with non-alcoholic fatty liver (NAFLD) and non-alcoholic steatohepatitis (NASH)
    Miette, Veronique
    Fournier, Celine
    Adara, Linda
    Sandrin, Laurent
    2007 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1-6, 2007, : 1333 - 1336
  • [24] Nonalcoholic Fatty Liver Disease after Liver Transplantation for Cryptogenic Cirrhosis or Non-Alcoholic Steatohepatitis.
    Pecoraro, Julieta
    Silvana, Ocampo
    Videla, Maria G.
    Yantorno, Silvina
    Schelotto, Pablo Barros
    Gondolesi, Gabriel
    Vigliano, Carlos
    Gonzalez, Pedro
    Laghens, Ruben
    Descalzi, Valeria
    LIVER TRANSPLANTATION, 2014, 20 : S287 - S287
  • [25] Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Verma, Siddharth
    Jensen, Donald
    Hart, John
    Mohanty, Smruti R.
    LIVER INTERNATIONAL, 2013, 33 (09) : 1398 - 1405
  • [26] FUNCTIONAL PATHWAY ANALYSIS OF GENE EXPRESSION IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND NON-ALCOHOLIC STEATOHEPATITIS (NASH)
    Stepanova, M.
    Manyam, G.
    Hossain, N.
    Chandhoke, V.
    Baranova, A.
    Goodman, Z.
    Younossi, Z.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S313 - S313
  • [27] Molecular Mechanisms of Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH)
    Ota, Tsuguhito
    CAROTENOIDS: BIOSYNTHETIC AND BIOFUNCTIONAL APPROACHES, 2021, 1261 : 223 - 229
  • [28] Leucine synergizes with metformin and sildenafil to treat Non-Alcoholic Fatty Liver Disease (NAFLD) and Steatohepatitis (NASH)
    Zemel, Michael
    Bruckbauer, Antje
    Xue, Bingzhong
    Shi, Hang
    HEPATOLOGY, 2015, 62 : 668A - 669A
  • [29] SURGICAL TREATMENT OF NONALCOHOLIC STEATOHEPATITIS AND NON-ALCOHOLIC FATTY LIVER DISEASE
    Ilias, Elias Jirjoss
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2010, 56 (04): : 381 - 381
  • [30] A Non-Invasive Prediction Model for Non-Alcoholic Steatohepatitis (NASH) in Pediatric Patients with Non-Alcoholic Fatty Liver Disease (NAFLD)
    Eng, Katharine
    Lopez, Rocio
    Nobili, Valerio
    Alkhouri, Naim
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S114 - S115
12345